Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Mar 1;118(5):1202-11.
doi: 10.1002/cncr.26439. Epub 2011 Jul 28.

Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancer

Soley Bayraktar  1 , Leonel F Hernadez-Aya, Xiudong Lei, Funda Meric-Bernstam, Jennifer K Litton, Limin Hsu, Gabriel N Hortobagyi, Ana M Gonzalez-Angulo
Affiliations

Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancer

Soley Bayraktar et al. Cancer. .

Abstract

Background: Recent observational studies have shown that metformin use in diabetic patients decreases both cancer incidence and mortality. Metformin use is also independently predictive of pathologic complete response. In the current study, the authors explored the association between metformin use and survival outcomes in patients with triple receptor-negative breast cancer (TNBC) who were receiving adjuvant chemotherapy.

Methods: The Breast Cancer Management System database of The University of Texas MD Anderson Cancer Center identified 1448 women who received adjuvant chemotherapy for TNBC between 1995 and 2007. Patients were categorized by diabetes status and metformin use. The Kaplan-Meier product-limit method was used to calculate distant metastasis-free survival (DMFS), recurrence-free survival (RFS), and overall survival (OS). Cox proportional hazards models were fit to determine the association between metformin use and survival outcomes.

Results: The study cohort was comprised of 63 diabetic patients receiving treatment with metformin, 67 diabetic patients not receiving metformin, and 1318 nondiabetic patients. Patients in the diabetic groups tended to be older (P = .005); more diabetic patients were postmenopausal (P = .0007), black (P = .0001), and obese (P < .0001). At a median follow-up of 62 months, there were no significant differences with regard to 5-year DMFS (P = .23), RFS (P = .38), and OS (P = .58) between the 3 groups. Compared with the metformin group, patients who did not receive metformin (hazard ratio [HR], 1.63; 95% confidence interval [95% CI], 0.87-3.06 [P = .13]) and nondiabetic patients (HR, 1.62; 95% CI, 0.97-2.71 [P = .06]) tended to have a higher risk of distant metastases.

Conclusions: The findings of the current study suggest that metformin use during adjuvant chemotherapy does not significantly impact survival outcomes in diabetic patients with TNBC.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Kaplan-Meier estimates of distant metastasis-free survival (DMFS) (1A), recurrence-free survival (RFS) (1B) and overall survival (OS) (1C) stratified by study groups (metformin, non-metformin and non-diabetic); Hazard functions for distant metastasis (1D), recurrence (1E), and death (1F) stratified by groups; Hazard ratios (HR) of distant metastasis (1G), recurrence (1H), and death (1I) for nonmetformin vs. metformin and non-diabetic vs. metformin groups among patients with triple-negative breast cancer.
See this image and copyright information in PMC

References

    1. Richardson LC, Pollack LA. Therapy insight: Influence of type 2 diabetes on the development, treatment and outcomes of cancer. Nat Clin Pract Oncol. 2005;2(1):48–53. - PubMed
    1. Frasca F, Pandini G, Sciacca L, et al. The role of insulin receptors and IGF-I receptors in cancer and other diseases. Arch Physiol Biochem. 2008;114(1):23–37. - PubMed
    1. Lipscombe LL, Goodwin PJ, Zinman B, McLaughlin JR, Hux JE. Increased prevalence of prior breast cancer in women with newly diagnosed diabetes. Breast Cancer Res Treat. 2006;98(3):303–309. - PubMed
    1. Wolf I, Sadetzki S, Gluck I, et al. Association between diabetes mellitus and adverse characteristics of breast cancer at presentation. Eur J Cancer. 2006;42(8):1077–1082. - PubMed
    1. Hjartaker A, Langseth H, Weiderpass E. Obesity and diabetes epidemics: cancer repercussions. Adv Exp Med Biol. 2008;630:72–93. - PubMed

Publication types

MeSH terms